These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10086795)

  • 1. Infections in adults undergoing unrelated donor bone marrow transplantation.
    Williamson EC; Millar MR; Steward CG; Cornish JM; Foot AB; Oakhill A; Pamphilon DH; Reeves B; Caul EO; Warnock DW; Marks DI
    Br J Haematol; 1999 Mar; 104(3):560-8. PubMed ID: 10086795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectious complications in patients undergoing unrelated donor bone marrow transplantation: experience from a single institution.
    Saavedra S; Jarque I; Sanz GF; Moscardó F; Jiménez C; Martín G; Plumé G; Regadera A; Martínez J; De La Rubia J; Acosta B; Pemán J; Pérez-Bellés C; Gobernado M; Sanz MA
    Clin Microbiol Infect; 2002 Nov; 8(11):725-33. PubMed ID: 12445010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients.
    Jantunen E; Ruutu P; Niskanen L; Volin L; Parkkali T; Koukila-Kähkölä P; Ruutu T
    Bone Marrow Transplant; 1997 Apr; 19(8):801-8. PubMed ID: 9134172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection.
    Sparrelid E; Hägglund H; Remberger M; Ringdén O; Lönnqvist B; Ljungman P; Andersson J
    Bone Marrow Transplant; 1998 Oct; 22(8):795-800. PubMed ID: 9827978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early infections in adult patients undergoing unrelated donor cord blood transplantation.
    Saavedra S; Sanz GF; Jarque I; Moscardó F; Jiménez C; Lorenzo I; Martín G; Martínez J; De La Rubia J; Andreu R; Mollá S; Llopis I; Fernández MJ; Salavert M; Acosta B; Gobernado M; Sanz MA
    Bone Marrow Transplant; 2002 Dec; 30(12):937-43. PubMed ID: 12476288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients.
    O'Donnell MR; Schmidt GM; Tegtmeier BR; Faucett C; Fahey JL; Ito J; Nademanee A; Niland J; Parker P; Smith EP
    J Clin Oncol; 1994 Apr; 12(4):827-34. PubMed ID: 8151325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infections among allogeneic bone marrow transplant recipients in India.
    George B; Mathews V; Srivastava A; Chandy M
    Bone Marrow Transplant; 2004 Feb; 33(3):311-5. PubMed ID: 14647246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus infection in recipients of related and unrelated donor bone marrow transplants: no evidence of increased incidence in patients receiving unrelated donor grafts.
    Foot AB; Pamphilon D; Caul EO; Roome AP; Hunt LP; Cornish JM; Oakhill A
    Br J Haematol; 1998 Aug; 102(3):671-7. PubMed ID: 9722292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD.
    Topolsky D; Crilley P; Styler MJ; Bulova S; Brodsky I; Marks DI
    Bone Marrow Transplant; 1996 Apr; 17(4):549-54. PubMed ID: 8722353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.
    van Burik JA; Carter SL; Freifeld AG; High KP; Godder KT; Papanicolaou GA; Mendizabal AM; Wagner JE; Yanovich S; Kernan NA
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1487-98. PubMed ID: 18022579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
    Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome.
    Morrison VA; Haake RJ; Weisdorf DJ
    Am J Med; 1994 Jun; 96(6):497-503. PubMed ID: 8017446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious complications following T-cell depleted hematopoietic stem-cell transplantation.
    Novitzky N; Rouskova A
    Cytotherapy; 2001; 3(3):165-73. PubMed ID: 12171723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors.
    Young JH; Logan BR; Wu J; Wingard JR; Weisdorf DJ; Mudrick C; Knust K; Horowitz MM; Confer DL; Dubberke ER; Pergam SA; Marty FM; Strasfeld LM; Brown JWM; Langston AA; Schuster MG; Kaul DR; Martin SI; Anasetti C;
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):359-370. PubMed ID: 26409243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gram-negative bacteraemia (GNB) after 428 unrelated donor bone marrow transplants (UD-BMT): risk factors, prophylaxis, therapy and outcome.
    Mitchell AE; Derrington P; Turner P; Hunt LP; Oakhill A; Marks DI
    Bone Marrow Transplant; 2004 Feb; 33(3):303-10. PubMed ID: 14647252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transplant infections: single center experience from the developing world.
    Ullah K; Raza S; Ahmed P; Chaudhry QU; Satti TM; Ahmed S; Mirza SH; Akhtar F; Kamal K; Akhtar FM
    Int J Infect Dis; 2008 Mar; 12(2):203-14. PubMed ID: 17920999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.
    Mehta RS; Peffault de Latour R; DeFor TE; Robin M; Lazaryan A; Xhaard A; Bejanyan N; de Fontbrune FS; Arora M; Brunstein CG; Blazar BR; Weisdorf DJ; MacMillan ML; Socie G; Holtan SG
    Haematologica; 2016 Jun; 101(6):764-72. PubMed ID: 27036159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors.
    Soiffer RJ; Weller E; Alyea EP; Mauch P; Webb IL; Fisher DC; Freedman AS; Schlossman RL; Gribben J; Lee S; Anderson KC; Marcus K; Stone RM; Antin JH; Ritz J
    J Clin Oncol; 2001 Feb; 19(4):1152-9. PubMed ID: 11181681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spectrum of non-Candida fungal infections following bone marrow transplantation.
    Morrison VA; Haake RJ; Weisdorf DJ
    Medicine (Baltimore); 1993 Mar; 72(2):78-89. PubMed ID: 8479326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.